Instant International
Written by: Liang Kaiyi
2021-05-19 09:56
Last update date: 2021-05-19 09:56
On May 17th, the Chilean Ministry of Health updated the protective effect of China's Coxing New Coronavirus Pneumonia (COVID-19) vaccine "real world study".
Data show that 14 days after the second dose of vaccine, the effective rate of preventing entry into the intensive care unit was 90.3%, and the effective rate of preventing death from infection was 86%.
The data also pointed out that 14 days after the second dose of Kexing vaccine, the effective rate of preventing symptomatic infection was 65.3%, and the effective rate of preventing hospitalization was 87%.
The picture shows a person vaccinated with Kexing's new crown vaccine on May 17, 2021 in Bangkok, Thailand.
(Associated Press)
Rafael Araos, an adviser to the Chilean Ministry of Health, who led the study, said that after months of tracking, the data accumulated so far is "reliable and positive", proving that despite the epidemic of the new coronavirus, the Coxing vaccine still has Better protection effect.
He said that with the passage of time, the assessment of the protective effect of Kexing's new crown vaccine will become more accurate and closer to the real situation.
It is reported that the Chilean Ministry of Health will also update relevant data monthly.
The Deputy Minister of Health of Chile, Paula Daza, said that the data released by this study once again proves the importance of universal vaccination. The vaccine used in Chile is effective in preventing symptomatic infections, reducing hospital admissions and preventing deaths caused by new crown infections.
Chile launched a nationwide large-scale vaccination of the new crown vaccine on February 3.
As of May 16, the total number of vaccinations in Chile was 16.57 million, of which more than 80% were China's Coxing New Crown vaccine.
The Chilean Ministry of Health first released the protective effect of the Coxing vaccine "real world study" on April 16.
The first published data showed that the effective rate of preventing symptomatic infections 14 days after the second dose of vaccine was 67%, the effective rate of preventing hospitalization was 85%, and the effective rate of preventing entry into the intensive care department was 89%. The effective rate of causing death is 80%.
Brazil will suspend the production of Kexing vaccines, saying that the supply of raw materials in China has encountered delays in customs clearance
The epidemic situation in small towns in Indonesia and Brazil has stabilized.
China Kexing Vaccine｜Indonesia study: 100% prevention of death cases within 7 days of vaccination
Duterte: Philippines accepts Chinese vaccine but South China Sea sovereignty will not compromise
China Kexing New Crown Vaccine Vaccine New Crown Pneumonia Global Outbreak Chile